In summary, the decreased BDNF levels in the blood and brains of Alzheimer’s disease patients suggest that BDNF is imperative in the etiology of Alzheimer’s disease and thus has the potential to be employed as a biomarker for the early detection of Alzheimer’s disease. This evidence concerns the gene BDNF and early-onset autosomal dominant Alzheimer disease.